TABLE 4.
Name | HIA | C2P | Solubility Log S (ESOL) | Lipophilicity Log Po/w (iLOGP) | BBB | P‐GpI | CYP2C9 | Clearance | Lipinski Violation | Carcinogens | Acute Oral Toxicity | HERG Inhibition | Rat LD50 (mol/kg) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chabamide I | 1 | −0.55 | MS (−5.89) | 4.18 | 0.905 | I (0.8730) | NI (0.6181) | 0.04 | 1; MW > 500 | NC (0.8213) | III (0.7133) | WI (0.9309) | 3.365 |
Chingchengenamide A | 1 | 0.5851 | S (−4.00) | 3.67 | 0.9788 | NI (0.5372) | I (0.5713) | 0.334 | 0 | NC (0.8624) | III (0.6087) | WI (0.9808) | 2.712 |